Radiopharmaceuticals in Nuclear Medicine Market By Product Type (Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals, Enriched Stable Isotopes), By Applications (Diagnostic Application, Therapeutic Application, Research, Pharmaceutical, Other), and By Region - Overall In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry Insights 2020 - 2026

Medical Devices Syndicate Market Research Pages: 125 Report ID: 6210

COVID-19

To Understand How COVID-19 Impact is Covered in this Report

Report Description

This report is a comprehensive study providing a detailed analysis of the radiopharmaceuticals in nuclear medicine market. The report defines the product type of radiopharmaceuticals in nuclear medicine along with its applications in various industry verticals with reference to various regions and major countries. Further, the study has identified and studied all the major players operating in the global radiopharmaceuticals in nuclear medicine market space and equated based on various parameters such as market revenue, annual sales volume, historical growth rate, and business strategies. Based on all these insights, the global radiopharmaceuticals in nuclear medicine market report recommends a business strategy for the current market participants to strengthen their market positions. Moreover, the report also suggests a market entry strategy for the new market entrants.

Furthermore, the radiopharmaceuticals in nuclear medicine market report has also identified the major vendors and distributors operating in all the major regions. This analysis and data is expected to help the market players to strengthen their market distribution channels and expand their geographical reach.

Radiopharmaceuticals in Nuclear Medicine Market Strategic Analysis 

The radiopharmaceuticals in nuclear medicine market report has analyzed the market using various marketing tools such as Porter’s Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis. In Porter’s Five Forces analysis, the market dynamics and factors such as the threat of substitute for radiopharmaceuticals in nuclear medicine, threat of new entrants in the radiopharmaceuticals in nuclear medicine market, bargaining power of buyers, bargaining power of suppliers to radiopharmaceuticals in nuclear medicine providing companies, and internal rivalry among the radiopharmaceuticals in nuclear medicine providers are analyzed to provide the readers of the report with a detailed view of the market current dynamics.

This analysis helps the users of the report to evaluate the radiopharmaceuticals in nuclear medicine market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, the impact of advertisements, and impact of consumer’s preferences. This all summarized data is anticipated to help the key decision-makers of the industry in the decision-making process. Further, this analysis also answers the imperative question for new entrants to enter the radiopharmaceuticals in nuclear medicine market or not.

Radiopharmaceuticals in Nuclear Medicine Market Key Trends Analysis

The report has analyzed the major factors which are impacting the growth of radiopharmaceuticals in nuclear medicine market. Driving factors that are positively impacting the demand for radiopharmaceuticals in nuclear medicine and restraining factors that are hindering the growth of radiopharmaceuticals in nuclear medicine market are discussed in detail along with their impacts on the global radiopharmaceuticals in nuclear medicine market. Further, the trends which are shaping the market and impacting the growth of the market are identified and discussed in detail in the reported study. Moreover, other qualitative factors such as risks associated with the operations and major challenges faced by the players in the market space are included in the report.

Radiopharmaceuticals in Nuclear Medicine Market Key Segment Analysis

The study provides a decisive view on the radiopharmaceuticals in nuclear medicine by segmenting the market based on product type, applications, and region. All the segments of the radiopharmaceuticals in nuclear medicine market have been analyzed based on present and future trends. The data for the market and its segments are forecast for 2020 to 2026. The report has identified the segments contributing most to the overall market growth in terms of revenue along with the factors boosting their growth.

Based on product type, the global radiopharmaceuticals in nuclear medicine market is segmented into Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals, Enriched Stable Isotopes. Detailed qualitative as well as quantitative product type segment analysis will be provided in the report for 2016 to 2026.

Based on applications market is segmented into Diagnostic Application, Therapeutic Application, Research, Pharmaceutical, Other. Various potential opportunities and factors affecting the different applications are analyzed and included in the report study.

Radiopharmaceuticals in Nuclear Medicine Market Regional Trends and Market Player’s Analysis

Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Wherein, North America dominated the global radiopharmaceuticals in nuclear medicine market in 2019. Over the forecast period, the Asia Pacific region is anticipated to witness the highest CAGR for the radiopharmaceuticals in nuclear medicine market. 

Radiopharmaceuticals in Nuclear Medicine Market Size By Region

Get more information about this report - Request Free Sample Copy

Major companies holding significant market shares in the global radiopharmaceuticals in nuclear medicine market are analyzed considering their market revenue, market shares, business strategies, recent developments, and growth rates. Recent events for these companies such as new solution/product launches, research initiatives, acquisitions, geographical expansions, and technological advancements are considered in finalizing their position in the radiopharmaceuticals in nuclear medicine market player positioning. The information provided in the radiopharmaceuticals in nuclear medicine market research study is expected to be helpful for all the key stakeholders of the radiopharmaceuticals in nuclear medicine value chain and technology ecosystem.

The report provides company market share analysis in order to give a broader overview of the key players in the radiopharmaceuticals in nuclear medicine market. Major players in the global radiopharmaceuticals in nuclear medicine market are Bracco Imaging S.P.A., Cambridge Isotope Laboratories Inc., Cardinal Health Inc., Covidien Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Isotec Inc. (Sigma-Aldrich), Lantheus Medical Imaging Inc., Nordion Inc., Ntp Radioisotopes (Pty) Ltd., Siemens Healthcare (Subsidiary Of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries Ltd. Inc., Australian Nuclear Association And Technology Organization (ANSTO), Board of Radiation And Isotope Technology (BRIT), Institute of Atomic Energy Polatom Radioisotope Centre, Institute of Isotopes Co. Ltd., Institute Of Radioelement (IRE), among others.

Scope of the report

Report Scope Details
Base Year: 2019 Historical Data for: 2016 to 2018
Forecast Period: 2020 to 2026 Pages: 125
Market representation Revenue in USD Million & CAGR from 2020 to 2026
Geographies covered: USA, Canada, Mexico, Brazil, Argentina, U.K., Germany, Italy, France, Spain, China, Japan, India, Australia, Saudi Arabia, Qatar, UAE, South Africa, etc.
Segments covered: Product Type, and Applications
Companies covered: Bracco Imaging S.P.A., Cambridge Isotope Laboratories Inc., Cardinal Health Inc., Covidien Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Isotec Inc. (Sigma-Aldrich), Lantheus Medical Imaging Inc., Nordion Inc., Ntp Radioisotopes (Pty) Ltd., Siemens Healthcare (Subsidiary Of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries Ltd. Inc., Australian Nuclear Association And Technology Organization (ANSTO), Board of Radiation And Isotope Technology (BRIT), Institute of Atomic Energy Polatom Radioisotope Centre, Institute of Isotopes Co. Ltd., Institute Of Radioelement (IRE)
Report coverage Revenue forecast, company share, competitive landscape, growth factors and trends
Free customization scope (equivalent to 5 analyst working days) If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Major Highlights of the Radiopharmaceuticals in Nuclear Medicine Market report study:

  • A detailed look at the global radiopharmaceuticals in nuclear medicine Industry
  • The report analyzes the global radiopharmaceuticals in nuclear medicine market and provides its stakeholders with significant actionable insights
  • The report has considered all the major developments in the recent past, helping the users of the report with recent industry updates
  • The report study is expected to help the key decision-makers in the industry to assist them in the decision-making process
  • The study includes data on market intelligence, changing market dynamics, current and expected market trends, etc.
  • The report comprises an in-depth analysis of macroeconomic and microeconomic factors affecting the global radiopharmaceuticals in nuclear medicine market
  • Market Ecosystem and adoption across market regions
  • Major trends shaping the global radiopharmaceuticals in nuclear medicine market
  • Historical and forecast size of the radiopharmaceuticals in nuclear medicine market in terms of Revenue (USD Million) 
  • Recent industry development and consumer preference trends
  • Competitive Landscape and player positioning analysis for the global radiopharmaceuticals in nuclear medicine market
  • Key products and solution offerings by major players and business strategies adopted
  • Recommendations for new market entrants and current players operating in the market space 
  • Analysis of niche and potential segments (product type, applications, and regions/countries) anticipated to observed promising growth 
  • Key challenges faced by operating players in the market space
  • Analysis of major risks associated with the market operations 

The report segment of the global radiopharmaceuticals in nuclear medicine market as follows:

Global Radiopharmaceuticals in Nuclear Medicine Market: By Product Type

  • Diagnostic Radiopharmaceuticals
  • Therapy Radiopharmaceuticals
  • Enriched Stable Isotopes
Global Radiopharmaceuticals in Nuclear Medicine Market: By Applications
  • Diagnostic Application
  • Therapeutic Application
  • Research
  • Pharmaceutical
  • Other
Global Radiopharmaceuticals in Nuclear Medicine Market: By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:

  1. Research Institutes, consulting firm
  2. Companies aspire to enter the radiopharmaceuticals in nuclear medicine market
  3. Student and universities 
  4. Solution Providers, product providers, service providers, and other players in the radiopharmaceuticals in nuclear medicine market space
  5. Associated private firms and government bodies
  6. Individual who want to learn about radiopharmaceuticals in nuclear medicine market 

Frequently Asked Questions

These players adopted different strategies so as to hold major market share in this market. Some of the major players in Radiopharmaceuticals in Nuclear Medicine industry includes.

  • Bracco Imaging S.P.A.
  • Cambridge Isotope Laboratories Inc.
  • Cardinal Health Inc.
  • Covidien Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Isotec Inc. (Sigma-Aldrich)
  • Lantheus Medical Imaging Inc.
  • Nordion Inc.
  • Ntp Radioisotopes (Pty) Ltd.
  • Siemens Healthcare (Subsidiary Of Siemens AG)
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries Ltd. Inc.
  • Australian Nuclear Association And Technology Organization (ANSTO)
  • Board of Radiation And Isotope Technology (BRIT)
  • Institute of Atomic Energy Polatom Radioisotope Centre
  • Institute of Isotopes Co. Ltd.
  • Institute Of Radioelement (IRE)

Based on the Radiopharmaceuticals in Nuclear Medicine market analysis, North America is predicted to held the highest share in the Radiopharmaceuticals in Nuclear Medicine market during the forecast period.

The statistical data of the top market players of Radiopharmaceuticals in Nuclear Medicine industry can be obtained from the company profile section specified in the report. This section incorporates analysis of top player’s operating in the Radiopharmaceuticals in Nuclear Medicine industry as well as their last five-year revenue, segmental revenue, product offerings, key strategies adopted, and geographical revenue produced.

The study offers a decisive view on the Radiopharmaceuticals in Nuclear Medicine by segmenting the market based on Product Type, Applications, and region.

The report gives a nitty-gritty assessment of the market by featuring data on various viewpoints that incorporate drivers, restraints, opportunities, and threats. This data can assist stakeholders in making suitable decisions before investing.

The sample for Radiopharmaceuticals in Nuclear Medicine market report can be received on-demand from the website as and when required.Direct call services or 24*7 chat support are provided to procure the sample report.

  1. Preface
    1. Report Description and Scope
    2. Research Scope
    3. Research Methodology
      1. Market Research Process
      2. Market Research Methodology
  2. Executive Summary
    1. Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
    2. Radiopharmaceuticals in Nuclear Medicine Market: Snapshot
  3. Radiopharmaceuticals in Nuclear Medicine - Industry Analysis
    1. Radiopharmaceuticals in Nuclear Medicine: Market Dynamics
    2. Market Drivers
      1. Driver 1
      2. Driver 2
    3. Restraints
      1. Restraint 1
      2. Restraint 2
    4. Opportunity
      1. Government funding and support
    5. Porter’s Five Forces Analysis
    6. Market Attractiveness Analysis
      1. Market attractiveness analysis By Product
      2. Market attractiveness analysis By Application
      3. Market attractiveness analysis by Region
  4. Radiopharmaceuticals in Nuclear Medicine Market - Competitive Landscape
    1. Company market share analysis
      1. Global Radiopharmaceuticals in Nuclear Medicine Market: company market share, 2019
    2. Strategic development
      1. Acquisitions & mergers
      2. New Product launches
      3. Agreements, partnerships, collaborations and joint ventures
      4. Research and development and Regional expansion
    3. Price trend analysis
  5. Global Radiopharmaceuticals in Nuclear Medicine Market -Product Type Analysis
    1. Global Radiopharmaceuticals in Nuclear Medicine Market overview: By Product Type
      1. Global Radiopharmaceuticals in Nuclear Medicine Market share, By Product Type,2019 and 2026
    2. Diagnostic Radiopharmaceuticals
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Diagnostic Radiopharmaceuticals, 2016-2026 (USD Million)
    3. Therapy Radiopharmaceuticals
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Therapy Radiopharmaceuticals, 2016-2026 (USD Million)
    4. Enriched Stable Isotopes
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Enriched Stable Isotopes, 2016-2026 (USD Million)
  6. Global Radiopharmaceuticals in Nuclear Medicine Market -Applications Analysis
    1. Global Radiopharmaceuticals in Nuclear Medicine Market overview: By Applications
      1. Global Radiopharmaceuticals in Nuclear Medicine Market share, By Applications,2019 and 2026
    2. Diagnostic Application
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Diagnostic Application, 2016-2026 (USD Million)
    3. Therapeutic Application
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Therapeutic Application, 2016-2026 (USD Million)
    4. Research
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Research, 2016-2026 (USD Million)
    5. Pharmaceutical
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Pharmaceutical, 2016-2026 (USD Million)
    6. Other
      1. Global Radiopharmaceuticals in Nuclear Medicine Market by Other, 2016-2026 (USD Million)
  7. Global Radiopharmaceuticals in Nuclear Medicine Market - Regional Analysis
    1. Global Radiopharmaceuticals in Nuclear Medicine Market overview: by Region
      1. Global Radiopharmaceuticals in Nuclear Medicine Market share, by Region, 2019 and 2026
    2. North America
      1. North America Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
      1. North America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      1. North America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      1. U.S. Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      2. U.S. Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      3. Canada Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Canada Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      5. Mexico Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      6. Mexico Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
    3. Europe
      1. Europe Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
      1. Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      1. UK Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      2. UK Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      3. Germany Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Germany Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      5. France Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      6. France Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      7. Italy Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Italy Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      9. Spain Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      10. Spain Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      11. Netherlands Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      12. Netherlands Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      13. Rest of Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      14. Rest of Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
    4. Asia Pacific
      1. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
      1. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      1. China Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      2. China Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      3. Japan Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Japan Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      5. India Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      6. India Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      7. Australia Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Australia Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      9. South East Asia Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      10. South East Asia Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      11. South Korea Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      12. South Korea Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      13. Rest of Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      14. Rest of Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
    5. Latin America
      1. Latin America Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
      1. Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      1. Brazil Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      2. Brazil Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      3. Argentina Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Argentina Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      5. Chile Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      6. Chile Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      7. Rest of Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Rest of Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
    6. Middle East & Africa
      1. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
      1. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      1. GCC Countries Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      2. GCC Countries Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      3. Nigeria Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Nigeria Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      5. South Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      6. South Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
      7. Rest of Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Rest of Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Applications, 2016-2026 (USD Million)
  8. Company Profiles
    1. Bracco Imaging S.P.A.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    2. Cambridge Isotope Laboratories Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    3. Cardinal Health Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    4. Covidien Plc
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    5. Eczacibasi-Monrol
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    6. Fujifilm Holdings Corporation
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    7. GE Healthcare (Subsidiary Of General Electric Company)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    8. IBA Group
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    9. Isotec Inc. (Sigma-Aldrich)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    10. Lantheus Medical Imaging Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    11. Nordion Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    12. Ntp Radioisotopes (Pty) Ltd.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    13. Siemens Healthcare (Subsidiary Of Siemens AG)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    14. Taiyo Nippon Sanso Corporation
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    15. Urenco Limited
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    16. Rotem Industries Ltd. Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    17. Australian Nuclear Association And Technology Organization (ANSTO)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    18. Board of Radiation And Isotope Technology (BRIT)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    19. Institute of Atomic Energy Polatom Radioisotope Centre
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    20. Institute of Isotopes Co. Ltd.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    21. Institute Of Radioelement (IRE)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments

 

List of Figures

  1. Market research process
  2. Market research methodology
  3. Global Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
  4. Porter’s Five Forces Analysis
  5. Global Radiopharmaceuticals in Nuclear Medicine Market attractiveness, By Product Type
  6. Global Radiopharmaceuticals in Nuclear Medicine Market attractiveness, By Applications
  7. Global Radiopharmaceuticals in Nuclear Medicine market share, By Product Type, 2019 and 2026
  8. Global Radiopharmaceuticals in Nuclear Medicine Market by Diagnostic Radiopharmaceuticals, 2016-2026 (USD Million)
  9. Global Radiopharmaceuticals in Nuclear Medicine Market by Therapy Radiopharmaceuticals, 2016-2026 (USD Million)
  10. Global Radiopharmaceuticals in Nuclear Medicine Market by Enriched Stable Isotopes, 2016-2026 (USD Million)
  11. Global Radiopharmaceuticals in Nuclear Medicine market share, By Applications, 2019 and 2026
  12. Global Radiopharmaceuticals in Nuclear Medicine Market by Diagnostic Application, 2016-2026 (USD Million)
  13. Global Radiopharmaceuticals in Nuclear Medicine Market by Therapeutic Application, 2016-2026 (USD Million)
  14. Global Radiopharmaceuticals in Nuclear Medicine Market by Research, 2016-2026 (USD Million)
  15. Global Radiopharmaceuticals in Nuclear Medicine Market by Pharmaceutical, 2016-2026 (USD Million)
  16. Global Radiopharmaceuticals in Nuclear Medicine Market by Other, 2016-2026 (USD Million)
  17. Global Radiopharmaceuticals in Nuclear Medicine Market share, by Region, 2019 and 2026
  18. North America Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
  19. Europe Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
  20. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
  21. Latin America Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)
  22. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market, 2016-2026 (USD Million)

 

List of Tables

  1. Global Radiopharmaceuticals in Nuclear Medicine Market: snapshot
  2. Drivers of the Radiopharmaceuticals in Nuclear Medicine Market: impact analysis
  3. Restraints of the Radiopharmaceuticals in Nuclear Medicine Market: impact analysis
  4. North America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type,2016-2026 (USD Million)
  5. North America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Application,2016-2026 (USD Million)
  6. Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type,2016-2026 (USD Million)
  7. Europe Radiopharmaceuticals in Nuclear Medicine Market revenue, By Application,2016-2026 (USD Million)
  8. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type,2016-2026 (USD Million)
  9. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market revenue, By Application,2016-2026 (USD Million)
  10. Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type,2016-2026 (USD Million)
  11. Latin America Radiopharmaceuticals in Nuclear Medicine Market revenue, By Application,2016-2026 (USD Million)
  12. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Product Type,2016-2026 (USD Million)
  13. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market revenue, By Application,2016-2026 (USD Million)
  • Bracco Imaging S.P.A.
  • Cambridge Isotope Laboratories Inc.
  • Cardinal Health Inc.
  • Covidien Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Isotec Inc. (Sigma-Aldrich)
  • Lantheus Medical Imaging Inc.
  • Nordion Inc.
  • Ntp Radioisotopes (Pty) Ltd.
  • Siemens Healthcare (Subsidiary Of Siemens AG)
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries Ltd. Inc.
  • Australian Nuclear Association And Technology Organization (ANSTO)
  • Board of Radiation And Isotope Technology (BRIT)
  • Institute of Atomic Energy Polatom Radioisotope Centre
  • Institute of Isotopes Co. Ltd.
  • Institute Of Radioelement (IRE)

Request Sample

An Overview on Research Methodology used at Syndicate Market Research:

1.1 Research Methodology

The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.

To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.

1.2 Secondary Research

The secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • Internal and external proprietary databases, relevant patent and regulatory databases
  • National government documents, statistical databases and market reports
  • News articles, press releases and web-casts specific to the companies operating in the market

The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista

1.3 Primary Research

We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:

  • It provides first-hand information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/ clinical trial phase managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry end users

1.4 Models

Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:

  • Demographic data: Population split by segment
  • Macro-economic indicators: GDP, etc.
  • Industry indicators: Expenditure, infrastructure, sector growth and facilities.

Data is then cross checked by the expert panel.

1.4.1 Company Share Analysis Model

Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:

1.4.2 Revenue Based Modeling

Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.

1.5 Research Limitations

Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.

Why Choose Syndicate Market Research?

  • Assured Quality

    We focus on the quality and accuracy of the report

  • Customer's Satisfaction

    Our expert team will assist with all your research needs and customize the report

  • Analyst Support

    Get you queries resolved from our expert analysts before and after purchasing the report

  • Instant delivery

    Instant delivery in the form of a PDF/PPT/Word Doc to your email address, within 12 hours after receiving the full payment.

  • Inimitable Expertise

    Analysts will provide deep insights about the reports

  • Privacy Policy

    * We value your privacy and will never rent or sell your email address.

Blog Feed

Our Client

Syndicated market research
Exceptional Market Report

Comprehensive & Focused Market Reports Large Archive of Excellent Market and Industry Analysis Reports that Deliver Business Intelligence.

Domain Specific Analytics
Secured Payment Options

Safe & Secure Payment Solutions Enabled by SSL, we provide you numerous safe payment options for
risk-free transactions.

Customized Research Programme
Premium Customer Service

Superior Customer Experience We serve our
customers through calls, emails and live chats for 365 days, 24x7.

Copyright © 2021 Syndicate Market Research.All Rights Reserved.
Powered By Zion Market Research